On March 27th, the General Department of the State Drug Administration issued a notice to crack down on the illegal manufacture and sale of COVID-19 virus detection reagents. The notice said that it is necessary to strengthen supervision and inspection of relevant diagnostic reagent production and operation enterprises, third-party platforms for medical device online trading services and online sales enterprises. For illegal clues, drug supervision and management departments at all levels should promptly investigate and deal with them, and report the investigation to the State Pharmaceutical Products Supervision and Administration Bureau.
COVID-19 test paper is a reagent or method for detecting novel coronavirus nucleic acid. Novel coronavirus is different from a nuclear organism. Viruses have no cell structure and cannot be cultured like bacteria, and then observed under a microscope. They can only detect whether there is nucleic acid in the patient's secretion.